Skip to main content
. Author manuscript; available in PMC: 2015 Dec 24.
Published in final edited form as: Proteomics Clin Appl. 2008 Jul;2(0):1025–1035. doi: 10.1002/prca.200780137

Figure 4.

Figure 4

Comparison of endorepellin (red) and perlecan domain III (green) fluorescence for control renal biopsies (see text), patients with CAN and patients with acute rejection (AcR). Intensity and overlap of green and red fluorescence is shown in typical line-scans obtained using Metamorph software. Note the broad spread of endorepellin labeling, exceeding that of perlecan, in CAN. Abbreviations GBM-glomerular basement membrane, TBM-tubular basement membrane. (Magnification 600×) White bar in upper left panel = 200 μm.